Prosecution Insights
Last updated: October 04, 2026

Japan Science and Technology Agency

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics

8 pending office actions • 5 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 27 patents granted in the last 365 days

Analysis

The Japan Science and Technology Agency currently manages 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 7 distinct examiners, indicating that no two pending actions are currently before the same individual. This workload is distributed across 4 distinct art units, reflecting a variety of specialized topics within the pharmaceutical field.

NGUYEN, HAIDUNG D is identified as the busiest examiner for the portfolio, with 1 pending office action. Given that there are 7 pending office actions and 7 distinct examiners, every examiner involved is currently handling exactly one case. This distribution across 4 distinct art units suggests that the agency's research and patenting efforts are not limited to a single narrow sub-discipline.

The presence of 7 pending office actions shows the agency's engagement with the patent office. The 4 distinct art units involved provide a broader examination footprint than a single-unit portfolio. With the busiest examiner pending count at 1, the agency's prosecution risk is spread across multiple examiners and technical groups.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

8
Total Pending OAs
5
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (38%)
4
Medium (50%)
1
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (25%)
§112 only1 (12%)
Double-patenting + other2 (25%)
Multi-statute (no §101)3 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
12% of docket
0
Mechanical / Eng
0% of docket
3
Business / Other
38% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NGUYEN, HAIDUNG D 1 64.9% +28.4%
GRAVES, TIMOTHY P 1 81.2% +15.0%
CHAU, LISA N 1 25.2% +17.5%
SULLIVAN, STEPHANIE LAUREN 1 58.1% +40.9%
KUCHARCZK, JED A 1 80.2% +16.7%
KANG, TAE-SIK 1 58.2% +27.8%
NOBLE, MARCIA STEPHENS 1 67.0% +39.9%
CONNORS, ALEXANDRA F 1 23.9% +45.4%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18548109 SN-38 DERIVATIVE, NANO-PARTICLES CONTAINING SAID DERIVATIVE, MEDICINE, AND METHOD FOR PRODUCING SAID NANO-PARTICLES KUCHARCZK, JED A 2d overdue

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
19256222 Heteroelement-Containing Graphene NGUYEN, HAIDUNG D —
18863049 MEASUREMENT DEVICE AND MEASUREMENT METHOD GRAVES, TIMOTHY P —
18597912 ORDERED ALLOY FERROMAGNETIC NANOWIRE STRUCTURE AND METHOD FOR PRODUCING SAME CHAU, LISA N —
16346188 LIVER ORGANOID COMPOSITIONS AND METHODS OF MAKING AND USING SAME CONNORS, ALEXANDRA F —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18548109 SN-38 DERIVATIVE, NANO-PARTICLES CONTAINING SAID DERIVATIVE, MEDICINE, AND METHOD FOR PRODUCING SAID NANO-PARTICLES KUCHARCZK, JED A 2d overdue
19256222 Heteroelement-Containing Graphene NGUYEN, HAIDUNG D —
18863049 MEASUREMENT DEVICE AND MEASUREMENT METHOD GRAVES, TIMOTHY P —
18597912 ORDERED ALLOY FERROMAGNETIC NANOWIRE STRUCTURE AND METHOD FOR PRODUCING SAME CHAU, LISA N —
18292496 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PANCREATIC CANCER AND BILE DUCT CANCER SULLIVAN, STEPHANIE LAUREN —
17922802 CORE-SHELL PARTICLE, COMPOSITE, LIGHT-RECEIVING MEMBER FOR PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT KANG, TAE-SIK —
17661097 GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES NOBLE, MARCIA STEPHENS —
16346188 LIVER ORGANOID COMPOSITIONS AND METHODS OF MAKING AND USING SAME CONNORS, ALEXANDRA F —

Top Art Units

Art UnitApps
2855 1
1623 1
1728 1
1632 1
1634 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19256222 Heteroelement-Containing Graphene NGUYEN, HAIDUNG D — §102§103§112 Non-Final OA — Pending Jul 01, 2025
18863049 MEASUREMENT DEVICE AND MEASUREMENT METHOD GRAVES, TIMOTHY P 2855 §102§103§112 Non-Final OA — Pending Nov 05, 2024
18597912 ORDERED ALLOY FERROMAGNETIC NANOWIRE STRUCTURE AND METHOD FOR PRODUCING SAME CHAU, LISA N — §102§103 Non-Final OA — Pending Mar 07, 2024
18292496 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PANCREATIC CANCER AND BILE DUCT CANCER SULLIVAN, STEPHANIE LAUREN — §102§103§112DP Non-Final OA — Pending Jan 26, 2024
18548109 SN-38 DERIVATIVE, NANO-PARTICLES CONTAINING SAID DERIVATIVE, MEDICINE, AND METHOD FOR PRODUCING SAID NANO-PARTICLES KUCHARCZK, JED A 1623 §103DP Final Rejection 2d overdue Pending Aug 28, 2023
17922802 CORE-SHELL PARTICLE, COMPOSITE, LIGHT-RECEIVING MEMBER FOR PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT KANG, TAE-SIK 1728 §103 Final Rejection — Pending Nov 02, 2022
17661097 GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES NOBLE, MARCIA STEPHENS 1632 §112 Non-Final OA — Pending Apr 28, 2022
16346188 LIVER ORGANOID COMPOSITIONS AND METHODS OF MAKING AND USING SAME CONNORS, ALEXANDRA F 1634 §103Other Non-Final OA — Pending Apr 30, 2019

Managing Japan Science and Technology Agency's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month